Concepedia

Tetsuo Matsui

TM

Statistics

Publications

15

Citations

1K

H-Index

13

Active since

1967

Affiliations

Astellas Pharma (Japan)(Current)

Tetsuo Matsui is an author at Astellas Pharma (Japan) specializing in pharmacology, molecular pharmacology, and diabetes mellitus.

Publications per year

1967–2013

15

Publications

15

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

Takatoshi Soga, Takahide Ohishi, Tetsuo Matsui et al. · Biochemical and Biophysical Research Communications · 2004 · 374 citations

, , +14

Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function

Toshiyuki Takasu, Masashi Ukai, Shuichi Sato et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 310 citations

, , +6

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

S. Yoshida, Hirotsugu Tanaka, Hiroyuki Oshima et al. · Biochemical and Biophysical Research Communications · 2010 · 55 citations

, , +13

Review of the Mackerel Genera Scomber and Rastrelliger with Description of a New Species of Rastrelliger

Tetsuo Matsui · Copeia · 1967 · 46 citations

, , +8

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice

S. Yoshida, Takahide Ohishi, Tetsuo Matsui et al. · Biochemical and Biophysical Research Communications · 2010 · 43 citations

, , +16

1–5 of 15